Abstract:Abstract Abstract 2908 Objectives This study was to detect if there were abnormalities of membrane hemopoietic cytokine receptor expression on CD34+ bone marrow cells in MDS. Methods 34 newly diagnosed MDS(12 in low-risk and 22 in high-risk) cases and 32 normal controls were enrolled in this study. Their CD34+CD38+ and CD34+CD38- bone marrow cells and the expressions of stem cell factor receptor(SCF-R),erythropoietin receptor (EpoR), granulocyte colony-stimulating factor receptor (G-CSFR) and thrombopoietin receptor (TpoR) on those cells were measured by flow cytometry. Results The mean percentage of CD34+ BMMNCs of MDS cases in high risk[(2.94±4.79)%)] was significantly higher than that of control group[(0.95±1.06)%](P<0.05). The mean percentages of CD34+CD38+ cells were significantly lower in low risk and high risk groups[(86.98±6.83)% and (83.57±9.86)% respectively] than that in control group [(92.41±3.43)%], thus the percentage of CD34+CD38- cells was significantly higher in either low-risk or high-risk group[(13.03±6.84)% and (16.42±9.85)% respectively]than that in control group[(7.59±3.43)%](P<0.05). In control group, the mean percentage of antigen expression of EpoR was significantly lower in CD34+CD38+ cells [(17.72±20.24) %] than that in CD34+CD38- cells [(64.65±21.02)%](P<0.01), The expressions of SCF-R,G-CSFR and TpoR on CD34+CD38- cells were not significantly different from these on CD34+CD38+ cells. The expression of EpoR on CD34+CD38+ cells of low-risk and high-risk MDS groups[(7.01±6.82)% and (7.16±9.45)% respectively] were significantly lower than that of control group[(17.72±20. 24) %] (P<0.05), The expression of G-CSFR on CD34+CD38+ cells of low-risk and high-risk MDS groups[(22.65±12.14)% and (26.50±19.65)% respectively] were significantly lower than that of control group[(45.13±23.41)%](P<0.01). The amount of EpoR on CD34+CD38-cells of low-risk and high-risk MDS groups[(40.18±20.38)% and (28.58±17.00)% respectively] were significantly lower than that of control group[(64.65±21.02)%](P<0.01), The expression of TpoR on CD34+CD38- cells of low-risk and high-risk MDS groups[(4.46±7.45)% and (3.23±4.55)% respectively] were significantly lower than that of control group[(15.33±14.95)%](P<0.01). The incidence of cytopenia of MDS cases with low expression rates of hemopoietic cytokine receptors on CD34+cells were higher than that of MDS with high expression rates of hemopoietic cytokine receptors. Conclusions There were abnormalities of differentiation and membrane hemopoietic cytokine receptors expression of CD34+ bone marrow cells in MDS, which were associated with MDS cytopenia and might be useful for MDS diagnosis. Disclosures: No relevant conflicts of interest to declare.

Probe into the Apoptosis Rate of Bone Marrow Mononuclear Cells in Myelodysplastic Syndromes

Experiment Study of Apoptosis of Bone Marrow Cells and TNF-α in Myelodysplastic Syndromes

[Study on Apoptosis in Myelodysplastic Syndromes by DNA in Situ End Labelling Combined with APAAP].

Primary Study about Hematopoietic Cell Apoptosis on Bone Marrow Sections in Patients with Myelodysplastic Syndrome

Clinical significance of apoptosis of bone marrow cells in patients with myelodysplastic syndromes

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

Relationship Between Macrophages and Apoptosis in Patients with Myelodysplastic Syndromes

Measurement of Apoptosis and Tumor Necrosis Factor-Α(tnfα) in the Marrow of Patients with Mvelodvsplastic Svn Dromes

[Apoptotic Characteristics of CD34 Positive Cells in Myelodysplastic Syndromes].

Study about Proliferation and Apoptosis of Megakaryocytes in Patients with Myelodysplastic Syndromes

[Expression of CD133 in the Bone Marrow of Patients with Myelodysplastic Syndrome and Its Clinical Significance].

The Roles of SDF-1/CXCR4 Axis and Its Relationship with Apoptosis in the Myelodysplastic Syndromes.

Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome

Study on the Membrane Hemopoietic Cytokine Receptor Expression on Cd34+Bone Marrow Cells of the Patients with Myelodysplastic Syndromes

Apoptosis in human myelodysplastic syndrome CD34+ cells is modulated by the upregulation of TLRs and histone H4 acetylation via a β-arrestin 1 dependent mechanism

Analysis of the immunophenotype features of bone marrow cells of patients with myelodysplatic syndromes

Gene Expression Profiling of the Bone Marrow Mononuclear Cells from Patients with Myelodysplastic Syndrome

[Autophagy Level of Bone Marrow Mononuclear Cells in Patients with Myelodysplastic Syndromes].

[Expression of WT1 and PRAME Gene in Bone Marrow and Peripheral Blood Samples of Patients with Myelodysplastic Syndrome].

Analysis of Proliferation Characters of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Myelodysplastic Syndrome

Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes